Bluebird Bio Works to Resolve Financial Reporting Delays
Company Announcements

Bluebird Bio Works to Resolve Financial Reporting Delays

An announcement from Bluebird Bio (BLUE) is now available.

Bluebird bio, Inc. faces delays in filing its crucial financial reports due to restatements needed in their previous financial statements. The company has received notices from Nasdaq for non-compliance related to timely filing requirements and is working on a compliance plan to regain its standing. With granted extensions, they aim to submit all required documentation within the new deadlines and have communicated these developments publicly as per Nasdaq rules. Their securities remain listed as they work towards resolving these reporting issues.

Learn more about BLUE stock on TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskBluebird Bio’s Key Decisions and Shareholder Engagement in 2024
Catie PowersBLUE Earnings this Week: How Will it Perform?
TheFlyLargest borrow rate increases among liquid names
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App